statements for the 2nd quarter of 2017 ending on 30 June 2017, the Company would like to report factors that affect the financial performance for the 2nd quarter of the year 2017 as follows; Statements of

Company”) held on 7 November 2017, approving the reviewed consolidated financial statements for 3rd Quarter of 2017 ending on 30 September 2017, the Company and its subsidiaries would like to report factors

Public Company Limited (“the Company”) would like to report on Management Discussion and Analysis from the Separate and Consolidated Financial Statements of the year ended December 31, 2018. The details

IP: INTER PHARMA PUBLIC COMPANY LIMITED L&E: LIGHTING & EQUIPMENT PUBLIC COMPANY LIMITED PAP: PACIFIC PIPE PUBLIC COMPANY LIMITED PRINC: PRINCIPAL CAPITAL PUBLIC COMPANY LIMITED PSL: PRECIOUS SHIPPING

follows: Statements of Comprehensive Income for the 1st Quarter Ended March 31, 2020 Revenue from Hospital Operations Operation : Consolidated Profit & Loss Statement 1Q 1Q % Unit : THB million 2020 2019

“Company” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the three months period ended March 31

result, Krungthai ZMICO proposed to postpone the preparation and submission of the reviewed financial statements for the first quarter of 2020. Since Krungthai ZMICO’s financial statements is important to

criteria, the transaction size is 3.99%. This evaluation is in accordance with total value criteria of the return which is compared with total assets value of the consolidated financial statements of company

the following details. Financial performance Statement of income Consolidated financial statements for the 9-month ended 30 September 2017 30 September 2018 Change (Reviewed/Restated) (Reviewed

size from the highest analyzed value, based on the net value of tangible assets, is subjected to 0.66% of net tangible assets of the consolidated financial statements as at 31 December 2018. And when